3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
182
Leukemia
128
Lymphoma
91
Leukemia, Myeloid, Acute
83
Myelodysplastic Syndromes
64
Burkitt Lymphoma
59
Lymphoma, Non-Hodgkin
53
Lymphoma, Large B-Cell, Diffuse
42
Leukemia, Myeloid, Accelerated Phase
39
Leukemia, Lymphocytic, Chronic, B-Cell
39
Lymphoma, Mantle-Cell
38
Hodgkin Disease
38
Graft vs Host Disease
36
Blast Crisis
35
Congenital Abnormalities
34
Multiple Myeloma
33
Lymphoma, Follicular
33
Leukemia, Myeloid, Chronic-Phase
33
Myeloproliferative Disorders
32
Recurrence
30
Breast Neoplasms
29
Leukemia, Myelomonocytic, Chronic
28
Primary Myelofibrosis
26
Lymphoma, Large-Cell, Immunoblastic
26
Lymphoma, B-Cell, Marginal Zone
25
Neoplasms, Plasma Cell
22
Osteosarcoma
21
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
21
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
20
Leukemia, Biphenotypic, Acute
20
Interventions
Dexamethasone
8
Bortezomib
7
Cyclophosphamide
6
Lenalidomide
4
isatuximab
3
glucarpidase
3
Calcium Dobesilate
3
Thalidomide
2
Kidney Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
pomalidomide
1
gamma-Glutamyl Hydrolase
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
auricularum
1
Whole-Body Irradiation
1
Urination
1
Urinalysis
1
Stents
1
Standard of Care
1
Rituximab
1
Ranitidine
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Methotrexate
1
Leucovorin
1
Ice
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Renal Insufficiency
×
Methotrexate
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts